Home / Posts of the author thibaut

Auteur/autrice : thibaut

Tête à Tête décideurs – Pierre Langlade Demoyen, ...

Invectys : lutter contre toutes les formes de cancers Avec 382 000 nouveaux cas et 157 400 décès par an, le cancer demeure une priorité absolue en matière de…

Read more

Invectys’ pipeline

Pipeline Depth Underpinned by Multiple Indications and Platforms Invectys Inc. develops a full range of innovative and very promising immunotherapeutic oncology…

Read more

About Invectys Inc.

Invectys is a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancers. …

Read more

Board of Directors

To help us orient our long-term decisions and strategy, we rely on an experienced and dependable board of seasoned industry professionnals, investors and health…

Read more

HLA-G: a powerful immune checkpoint

Monoclonal antibodies targeting checkpoint inhibitors are hugely important immunotherapy molecules for the treatment cancers…

Read more

Scientific Advisory Board

Invectys’ Scientific and Clinical Board is composed of globally recognized top specialists and key opinion leaders: Professor Maurizio Zanetti, M.D. A professor…

Read more

DNA Vaccination

The main product of Invectys is a DNA vaccine targeting Telomerase…

Read more

Senior Management Team

​Invectys Inc. is led by a team of experienced industry professionals, combining vision, scientific knowledge and management skills. Praveen Tyle, Ph.D., President…

Read more